Navigation Links
Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
Date:1/17/2008

Former Electrophysiologist at Cleveland Clinic Brings Extensive Experience in the Use of Interventional Magnetic Navigation Systems in the Treatment

of Cardiovascular Disease

ST. LOUIS, Jan. 17 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today the appointment of J. David Burkhardt, M.D., F.A.C.C., as Chief Medical Officer. Dr. Burkhardt was most recently the Associate Program Director for the Clinical Cardiac Electrophysiology Fellowship training program and he directed the Clinical Electrophysiology curriculum at the Lerner Case Western Reserve School of Medicine at the Cleveland Clinic.

"We are very pleased that David has joined the Stereotaxis executive team," said Bevil J. Hogg, Chief Executive Officer of Stereotaxis. "He is renowned in the field of cardiac electrophysiology and has extensive experience in the use of robotic navigation systems, including the Stereotaxis Niobe System. Through his authorship of numerous peer-reviewed publications and abstracts, as well as speaking engagements at professional conferences worldwide, David has established himself as an expert in his field. He brings a much-valued perspective as a practicing cardiac electrophysiologist to Stereotaxis' mission to provide the safest, most effective standard of care in the treatment of cardiac arrhythmias."

"I am thrilled to be joining Stereotaxis at this very important time, with the FDA approval of the irrigated tip catheter," said Dr. Burkhardt. "While at the Cleveland Clinic, I had the opportunity to evaluate several new technologies, and performed more than 300 cases with the Stereotaxis Niobe System. I believe that Stereotaxis has the ability to revolutionize the way electrophysiology and interventional procedures are performed."

Dr. Burkhardt is board certified in Internal Medicine, Cardiovascular Medicine and Clinical Cardiac Electrophysiology. He received his Bachelor's and Medical degrees from
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
2. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
3. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
4. Codexis Appoints Singapore Laboratories Managing Director
5. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
9. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. NeurogesX Appoints New Director to the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
(Date:1/14/2014)... , Jan. 14, 2014 The largest international ... medicinal plants and therapeutic derivatives thereof has endorsed ... and researchers about the challenges of adulterated herb ... ) The Society for Medicinal ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
(Date:1/14/2014)... , Jan. 14, 2014   Kinaxis ®, provider of ... ) and sales and operations planning ( S&OP ) service, ... Biomanufacturing Summit , which will be held at the Hilton ... conference, join Kinaxis customer Elisabeth Kaszas , Director of ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... 2009 Earnings Guidance and Introduces Q1 2009 Guidance FRAZER, ... . (Nasdaq: CEPH ) today reported 2008 ... billion for 2007, exceeding the company,s previously issued guidance. ... year 2008 was $3.27. Excluding amortization expense and ...
... VOLC ), a leader in the development, ... of coronary and peripheral artery,disease, said today that it ... Growth Stock Conference on Wednesday, February 18. , ... and chief executive,officer, will begin at 9:30 a.m., Pacific ...
... Calif., Feb. 12 iZumi Bio, Inc., announced,today the ... and a,member of the company,s Board of Directors. ... Inc. which merged with Transcept Pharmaceuticals,Inc. in January 2009. ... , iZumi Bio is focused ...
Cached Biology Technology:Cephalon's New Product Launches Pace Record 2008 Sales 2Cephalon's New Product Launches Pace Record 2008 Sales 3Cephalon's New Product Launches Pace Record 2008 Sales 4Cephalon's New Product Launches Pace Record 2008 Sales 5Cephalon's New Product Launches Pace Record 2008 Sales 6Cephalon's New Product Launches Pace Record 2008 Sales 7Cephalon's New Product Launches Pace Record 2008 Sales 8Cephalon's New Product Launches Pace Record 2008 Sales 9Cephalon's New Product Launches Pace Record 2008 Sales 10Cephalon's New Product Launches Pace Record 2008 Sales 11Cephalon's New Product Launches Pace Record 2008 Sales 12Cephalon's New Product Launches Pace Record 2008 Sales 13Cephalon's New Product Launches Pace Record 2008 Sales 14Cephalon's New Product Launches Pace Record 2008 Sales 15Cephalon's New Product Launches Pace Record 2008 Sales 16Cephalon's New Product Launches Pace Record 2008 Sales 17Cephalon's New Product Launches Pace Record 2008 Sales 18Cephalon's New Product Launches Pace Record 2008 Sales 19Cephalon's New Product Launches Pace Record 2008 Sales 20Cephalon's New Product Launches Pace Record 2008 Sales 21Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast 2iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer 2
(Date:4/23/2014)... (Apr. 23, 2014) People who have had a ... restore neurological function. However, a study conducted in Taiwan, ... Cell Transplantation , but is currently freely available ... , has found that when one group of stroke ... injected directly into the brain and a similar group ...
(Date:4/23/2014)... energy landscape in the U.S., but in some ... energy industry, residents and agricultural interests over already-scarce ... water quality is a potential risk unless there ... the ACS journal Environmental Science & Technology ... out that a major criticism of extracting shale ...
(Date:4/23/2014)... cli-fi, is a newly coined term for novels and films ... from University of Copenhagen shows how these fictions serve as ... consequences of climate change and imagine other living conditions. ... changes in the atmosphere; it is also a cultural phenomenon ... read and the films we see. And there are so ...
Breaking Biology News(10 mins):Autologous stem cell therapy improves motor function in chronic stroke victims 2How to avoid water wars between 'fracking' industry and residents 2Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3
... Researchers at the Swedish medical university Karolinska Institutet (KI) have ... parietal parts, to increase the understanding of the capacity of ... in the brain interact. One of the findings they have ... brain,s neuronal network that restricts the number of items we ...
... may one day help people who are not responding ... The Journal of Immunology . Scientists looking at ... to reduce the virus levels in the blood to ... called D-1mT alongside Anti-Retroviral Therapy (ART). Simian Immunodeficiency ...
... that its latest journal, Disease Models & Mechanisms ... MEDLINE. MEDLINE (http://www.pubmed.gov) is the premier bibliographic database of ... National Institutes of Health (NIH), MEDLINE contains over 16 million ... DMM has been recommended for inclusion by ...
Cached Biology News:Computer simulations explain the limitations of working memory 2Potential new HIV drug may help patients not responding to treatment 2Potential new HIV drug may help patients not responding to treatment 3Disease Models & Mechanisms -- selected for indexing in Medline 2
... Dyad thermal cycler is a flexible ... chassis accommodates a variety of interchangeable ... hold different types and numbers of ... with point-and-click navigation. Peltier heat pumps, ...
For demonstration of Helicobacter pylori...
... Disruption of the mitochondrial transmembrane ... earliest intracellular events that occur ... MitoLight Apoptosis Detection Kit utilizes ... MitoLight, as a mitochondrial activity ...
The PDS-1000 He Hepta system includes the PDS-1000 He biolistic system and the Hepta adaptor....
Biology Products: